I am humbled and grateful to share that the Johns Hopkins Carey Business School recently published a feature story highlighting my selection as a 2025 FortyUnder40 Award honoree. This recognition is deeply meaningful to me, not only as an alumnus of Carey but also as someone committed to advancing healthcare innovation, public health solutions, and equitable access to care across Ghana and beyond.

My Journey: Clinical Medicine, Public Health & Innovation

Before joining Carey for my MPH/MBA, I had spent nearly a decade practising as a physician in Ghana, working closely with patients whose health outcomes were often influenced by systemic barriers. Carey gave me the opportunity to expand my capacity to solve those systemic challenges — equipping me with training in Healthcare, Technology, and Innovation, strategic thinking, and the business acumen needed to scale impactful health solutions.

The Johns Hopkins article captured this pivotal part of my journey and how it continues to shape the work I do today. As a Senior Consultant in Life Sciences, I remain committed to bridging clinical care, data, and innovation to help organizations build more resilient, patient-centered health systems.

Staying Connected to Ghana & Our Shared Mission

Despite the global scope of my work, my passion for improving healthcare in Ghana remains at the core of everything I do. The FortyUnder40 Ghana Award and the Carey spotlight both reaffirm my commitment to strengthening preventive care, chronic-disease management, and community-centered health programs.

A Note of Gratitude

I extend my sincere thanks to the Johns Hopkins Carey Business School for sharing my story, and to every colleague, mentor, patient, and partner who has been part of this ongoing journey.

For those interested in learning more, I encourage you to read the full feature on the Carey website:
👉 Carey alum Emmanuel Elorm Nortey-Adom earns FortyUnder40 award

Thank you for being part of the DNA Plus community as we continue working toward better health outcomes for all.